GPC3 and hepatocellular carcinoma: For example, Zheng et al. conducted clinical trials investigating diverse GPC3-targeted therapy strategies in HCC therapy, including humanized anti-GPC3 cytotoxic antibody therapy, peptide vaccine administration, and immunotoxin treatments [56].